AWM
ASND icon

AE Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

AE Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,923
Closed -$529K – 1949
2023
Q2 		$529K Buy
+5,923
New +$515K ﹤0.01% 1364

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AE Wealth Management's ASND Position: Q3 2023 in Review

AE Wealth Management sold out of Ascendis Pharma A/S (ASND) in Q3 2023, closing a stake of 5,923 shares — an estimated $529K sold.

AE Wealth Management first reported a position in ASND in Q2 2023 and held it in 1 quarter. The position peaked at $529K in Q2 2023. 160 funds tracked by Wall St. Rank hold ASND as of Q3 2023.

  • AE Wealth Management reported no remaining Ascendis Pharma A/S position as of Q3 2023 after selling out during the quarter.
  • AE Wealth Management sold 5,923 Ascendis Pharma A/S shares in Q3 2023, an estimated $529K.
  • AE Wealth Management first reported a position in Ascendis Pharma A/S in Q2 2023 and held it in 1 quarter.
  • AE Wealth Management's Ascendis Pharma A/S position peaked at $529K in Q2 2023.
  • 160 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2023.

Based on AE Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.